British Patient Capital appoints Hazel Moore OBE as Non-Executive Director
06 June 2019: British Patient Capital (BPC) has appointed Hazel Moore, OBE as Non-Executive Director to the board of British Patient Capital Ltd, effective from 1 June 2019.
Hazel is the co-founder and Chair of FirstCapital, an investment bank which provides mergers and acquisitions, private equity and growth capital advice to high growth technology companies. She also currently chairs the Innovation Finance Sub-Committee for Innovate UK, the UK’s national innovation agency, having been a Governing Board member of Innovate UK until 2018. Hazel is a member of the Future Fifty advisory panel and was previously on the Investment Advisory Panel of the North West Fund.
Hazel was awarded an OBE in the 2017 New Years’ Honours list for services to entrepreneurship and innovation. She won the CBI/Real Business First Women in Finance award in 2016 and the Women in Private Equity Award for Best Corporate Finance Adviser in 2015.
Hazel Moore said: “I’ve worked with many growing businesses over the years and have seen first-hand the positive impact that strong, supportive financial backing can have on their ability to scale. I am delighted to work with British Patient Capital and I am excited about its potential to help accelerate high growth UK businesses through providing a source of long term capital.”
Keith Morgan, Chair of British Patient Capital, said: “Our mission is to enable long-term investment in innovative companies across the UK, led by ambitious entrepreneurs who want to build successful, world-class businesses. I look forward to working with Hazel and drawing on her expertise as we continue to build BPC as a major force in patient capital in the UK.”
About British Patient Capital
British Patient Capital is the trading name of British Patient Capital Limited, a wholly owned commercial subsidiary of British Business Bank plc, the UK government’s economic development bank. It forms part of the British Business Bank’s commercial arm.
Its mission is to enable long-term investment in innovative firms led by ambitious entrepreneurs who want to build large scale businesses. British Patient Capital has been given new resources of £2.5bn and will deliver a programme designed to support high growth potential innovative UK businesses in accessing the long-term financing they require to scale up. Find out more at britishpatientcapital.co.uk.
British Business Bank plc and its principal operating subsidiaries are not banking institutions and do not operate as such. Neither British Business Bank nor its principal operating subsidiaries are authorised or regulated by the Prudential Regulation Authority (PRA) or the Financial Conduct Authority (FCA). A complete legal structure chart for British Business Bank plc and its subsidiaries can be found on the British Business Bank plc websiteLink opens in a new window.